TrialThe Journal of clinical endocrinology and metabolism2022

Long-term Burosumab Administration Is Safe and Effective in Adults With X-linked Hypophosphatemia.

Thomas J Weber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.